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Abstract
Calcium-	and	sodium-	activated	potassium	channels	are	members	of	the	6TM	family	of	K	channels
which	comprises	the	voltage-gated	KV	subfamilies,	including	the	KCNQ	subfamily,	the	EAG	subfamily
(which	includes	hERG	channels),	the	Ca2+-activated	Slo	subfamily	(actually	with	6	or	7TM)	and	the
Ca2+-	and	Na+-activated	SK	subfamily	(nomenclature	as	agreed	by	the	NC-IUPHAR
Subcommittee	on	Calcium-	and	sodium-activated	potassium	channels	[125]).	As	for	the	2TM
family,	the	pore-forming	a	subunits	form	tetramers	and	heteromeric	channels	may	be	formed	within
subfamilies	(e.g.	KV1.1	with	KV1.2;	KCNQ2	with	KCNQ3).
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